![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA CONCERNED ABOUT NEW USE OF OSCIENT ANTIBIOTIC
FDA CONCERNED ABOUT NEW USE OF OSCIENT ANTIBIOTIC
The risk of skin rashes and other serious skin reactions seen with an Oscient Pharmaceuticals Corp. (OSCI) antibiotic outweighs possible benefits of using the drug to treat sinus infections, the Food and Drug Administration said Monday.
Market
Watch
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct